254 related articles for article (PubMed ID: 14505273)
21. Origin of the expansion mutation in myotonic dystrophy.
Imbert G; Kretz C; Johnson K; Mandel JL
Nat Genet; 1993 May; 4(1):72-6. PubMed ID: 8513329
[TBL] [Abstract][Full Text] [Related]
22. Myotonic dystrophy: RNA pathogenesis comes into focus.
Ranum LP; Day JW
Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
[TBL] [Abstract][Full Text] [Related]
23. Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec.
Yotova V; Labuda D; Zietkiewicz E; Gehl D; Lovell A; Lefebvre JF; Bourgeois S; Lemieux-Blanchard E; Labuda M; Vézina H; Houde L; Tremblay M; Toupance B; Heyer E; Hudson TJ; Laberge C
Hum Genet; 2005 Jul; 117(2-3):177-87. PubMed ID: 15883838
[TBL] [Abstract][Full Text] [Related]
24. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
26. A Z-DNA sequence reduces slipped-strand structure formation in the myotonic dystrophy type 2 (CCTG) x (CAGG) repeat.
Edwards SF; Sirito M; Krahe R; Sinden RR
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3270-5. PubMed ID: 19218442
[TBL] [Abstract][Full Text] [Related]
27. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
28. De novo myotonic dystrophy mutation in a Nigerian kindred.
Krahe R; Eckhart M; Ogunniyi AO; Osuntokun BO; Siciliano MJ; Ashizawa T
Am J Hum Genet; 1995 May; 56(5):1067-74. PubMed ID: 7726160
[TBL] [Abstract][Full Text] [Related]
29. Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in Taiwan: implications for low prevalence and founder mutations of Taiwanese myotonic dystrophy type 1.
Pan H; Lin HM; Ku WY; Li TC; Li SY; Lin CC; Hsiao KM
Eur J Hum Genet; 2001 Aug; 9(8):638-41. PubMed ID: 11528511
[TBL] [Abstract][Full Text] [Related]
30. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
31. Molecular Diagnosis of Myotonic Dystrophy.
Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
[TBL] [Abstract][Full Text] [Related]
32. French myotonic dystrophy families show expansion of a CTG repeat in complete linkage disequilibrium with an intragenic 1 kb insertion.
Lavedan C; Hofmann-Radvanyi H; Boileau C; Bonaïti-Pellié C; Savoy D; Shelbourne P; Duros C; Rabes JP; Dehaupas I; Luce S
J Med Genet; 1994 Jan; 31(1):33-6. PubMed ID: 8151634
[TBL] [Abstract][Full Text] [Related]
33. Reduction in size of the myotonic dystrophy trinucleotide repeat mutation during transmission.
O'Hoy KL; Tsilfidis C; Mahadevan MS; Neville CE; Barceló J; Hunter AG; Korneluk RG
Science; 1993 Feb; 259(5096):809-12. PubMed ID: 8094260
[TBL] [Abstract][Full Text] [Related]
34. Homozygosity for CCTG mutation in myotonic dystrophy type 2.
Schoser BG; Kress W; Walter MC; Halliger-Keller B; Lochmüller H; Ricker K
Brain; 2004 Aug; 127(Pt 8):1868-77. PubMed ID: 15231584
[TBL] [Abstract][Full Text] [Related]
35. Further evidence for a major ancient mutation underlying myotonic dystrophy from linkage disequilibrium studies in the Japanese population.
Yamagata H; Nakagawa M; Johnson K; Miki T
J Hum Genet; 1998; 43(4):246-9. PubMed ID: 9852676
[TBL] [Abstract][Full Text] [Related]
36. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2.
Bonifazi E; Vallo L; Giardina E; Botta A; Novelli G
Diagn Mol Pathol; 2004 Sep; 13(3):164-6. PubMed ID: 15322428
[TBL] [Abstract][Full Text] [Related]
37. Unexpected diagnosis of myotonic dystrophy type 2 repeat expansion by genome sequencing.
Rafehi H; Green C; Bozaoglu K; Gillies G; Delatycki MB; Lockhart PJ; Scheffer IE; Bahlo M
Eur J Hum Genet; 2023 Jan; 31(1):122-124. PubMed ID: 35945246
[TBL] [Abstract][Full Text] [Related]
38. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of Non-Pathogenic Premutation-Range Myotonic Dystrophy Type 2 Alleles.
Radvanszky J; Hyblova M; Radvanska E; Spalek P; Valachova A; Magyarova G; Bognar C; Polak E; Szemes T; Kadasi L
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501382
[TBL] [Abstract][Full Text] [Related]
40. Upgrading molecular diagnostics of myotonic dystrophies: multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs.
Radvansky J; Ficek A; Kadasi L
Mol Cell Probes; 2011 Aug; 25(4):182-5. PubMed ID: 21550396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
